Wordt geladen...
Regression of prostate tumors after intravenous administration of lactoferrin-bearing polypropylenimine dendriplexes encoding TNF-α, TRAIL, and interleukin-12
The possibility of using gene therapy for the treatment of prostate cancer is limited by the lack of intravenously administered delivery systems able to safely and selectively deliver therapeutic genes to tumors. Given that lactoferrin (Lf) receptors are overexpressed on prostate cancer cells, we hy...
Bewaard in:
| Gepubliceerd in: | Drug Deliv |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Taylor & Francis
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6058574/ https://ncbi.nlm.nih.gov/pubmed/29493296 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2018.1440666 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|